If your periods stopped in your thirties or very early forties, the advice written for women at 51 does not apply to you. Not a modified version of it — a different set of recommendations, made for different reasons.
The terminology first, because it's used loosely and the distinction matters.
Early menopause means menopause between 40 and 45. Around one in twenty women.
Premature ovarian insufficiency (POI) means it happens before 40. Around one in a hundred women, and roughly one in a thousand before 30.
"Insufficiency" rather than "failure" is deliberate. Ovarian function in POI is not always completely and permanently absent — it can fluctuate, and spontaneous pregnancy occurs in a small proportion of women after diagnosis. Uncommon, but not zero, which has consequences for contraception decisions.
Why the age matters medically
Estrogen does more than regulate reproduction. It's involved in maintaining bone density, in vascular function, and in aspects of brain and urogenital tissue health. Losing it at 51 means losing it at a point the body broadly anticipates. Losing it at 36 means fifteen additional years without it.
That's why early menopause is associated with increased long-term risk of osteoporosis and cardiovascular disease, and why the treatment logic inverts.
For a woman at 51 weighing hormone therapy, the conversation is about symptom relief against a small set of risks. For a woman at 36, hormone therapy is generally recommended until around the average age of natural menopause — roughly 51 — not primarily for symptoms but to replace what her body would otherwise be producing. NICE guidance and the ESHRE guideline both take this position. The risk framing that dominates public discussion of HRT is largely drawn from studies of women in their sixties and does not transfer to this group.
Getting diagnosed
POI is frequently missed, and the delays are long. The pattern is familiar: periods become irregular or stop, the woman is told she's too young, and years pass.
Diagnosis generally requires irregular or absent periods for at least four months, plus a raised FSH on two separate occasions at least four weeks apart. Testing is warranted — this is one of the situations where hormone testing genuinely is the right move, unlike in the over-45 group.
If your periods have stopped or become significantly irregular and you're under 40, that is a reason to be assessed rather than reassured. If you're between 40 and 45 with symptoms and a change in your cycle, testing may also be appropriate.
Be the first to know when we launch.
We'll only email you about the launch. See our privacy policy.
Causes, and the frustrating answer
In most cases of spontaneous POI, no cause is found. Known causes include chromosomal conditions such as Turner syndrome and fragile X premutation, autoimmune conditions, and treatment-related causes — chemotherapy, pelvic radiotherapy, or surgical removal of the ovaries.
Investigation usually includes a chromosome analysis, fragile X testing, and screening for associated autoimmune conditions including thyroid disease. Worth pursuing, partly because some findings carry implications for relatives.
Surgical menopause deserves its own note: when both ovaries are removed, hormone levels drop within hours rather than years. Symptoms are typically more abrupt and severe, and there is no gradual adjustment period.
The part that isn't clinical
The medical guidance for POI is comparatively clear. The rest of it is much harder, and it gets far less attention.
Being told at 34 that your ovaries have stopped is not the same experience as being told at 52. It can arrive alongside grief over fertility that may not be openly acknowledged, either by you or by the people around you. It can land in a life stage where nobody in your circle has any reference point. The support materials tend to be aimed at women fifteen years older, illustrated accordingly, and can compound the isolation rather than easing it.
Fertility options exist and depend on circumstances — donor eggs, and in some cases fertility preservation if treatment is anticipated. These conversations should happen early, with a specialist, and ideally before you've had to search for them yourself.
What to ask for
If you have been diagnosed with POI or early menopause, reasonable requests include: referral to a specialist with genuine menopause experience rather than general management; a discussion of hormone therapy until at least the average age of menopause; baseline bone density assessment; cardiovascular risk review; a fertility conversation if relevant; and psychological support, which is recommended in guidelines and rarely offered without asking.
You are entitled to all of it. Ask for it by name.
Sources
- European Society of Human Reproduction and Embryology. Guideline on the Management of Women with Premature Ovarian Insufficiency. ESHRE POI Guideline Development Group. - National Institute for Health and Care Excellence. Menopause: identification and management (NG23), section on premature ovarian insufficiency. 2015, updated 2024. - Webber L, Davies M, Anderson R, et al. ESHRE Guideline: management of women with premature ovarian insufficiency. Human Reproduction. 2016;31(5):926–937. - Faubion SS, Kuhle CL, Shuster LT, Rocca WA. Long-term health consequences of premature or early menopause and considerations for management. Climacteric. 2015;18(4):483–491.